Supply Chain
OpenMarkets recognized Port Jefferson Station, N.Y.-based Port Jefferson Surgery Center for its commitment to eliminating waste in the healthcare supply chain and improving equipment transactions, HealthCareBusiness Daily News reports.
Novartis will not raise prices for any of its U.S.-based prescription offerings in 2018, CNN reports.
The FDA granted Medtronic 510(k) clearance of KyphonHV-R Bone Cement for treatment of pathological sacral vertebral body fractures using sacral vertebroplasty or sacroplasty.
The FDA is launching a Drug Shortages Task Force to address shortages of medically necessary products.
Drugs and medical supplies comprise almost 25 percent of net revenue at ASCs nationwide, according to VMG Health's 2018 Multi-Specialty ASC Benchmarking Study.
Asking physicians to use products that align with their desired outcomes is more effective than convincing them to use new products just because they're less expensive, according to Quorum Purchasing Advantage Vice President Tony Bramer.
End-to-end solutions provider Viant appointed two new leaders after acquiring Advanced Surgical and Orthopedics and doubling in size, Medical Design and Outsourcing reports.
Physicians will present three abstracts supporting the EyePoint Pharmaceuticals' Yutiq three-year micro-insert for noninfectious posterior segment uveitis July 25.
The FTC approved Takeda's deal to acquire Shire for $62 billion, the company announced in a press release.
After President Donald Trump publicly criticized Pfizer's decision to raise the price of 41 of its drugs, the company announced it would delay the increase, the Chicago Tribune reports.